LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)

Q: What does CUSIP 528872302 represent in this 13F holders report?

CUSIP 528872302 is the security identifier for LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q2 2021?

105 institutional investors reported LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 528872302

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 427,442,892
Total 13F shares: 117,708,489
Share change: +818,560
Total reported value: $540,207,653
Put/Call ratio: 76%
Price per share: $4.59
Number of holders: 105
Value change: +$2,119,118
Number of buys: 63
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 528872302?
CUSIP 528872302 identifies LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 528872302:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Artal Group S.A.	13F	Company	17%	71,178,364	$417,817,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	2.1%	9,102,838	$53,434,000	—	31 Mar 2021	13F
BVF INC/IL	13F	Company	2%	8,394,000	$49,273,000	—	31 Mar 2021	13F
Ulys, L.L.C.	13F	Individual	1%	4,321,214	$25,366,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	0.93%	3,958,847	$23,238,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.91%	3,904,147	$22,916,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.7%	3,006,612	$17,649,000	—	31 Mar 2021	13F
NEA Management Company, LLC	13F	Company	0.56%	2,382,286	$13,984,000	—	31 Mar 2021	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.51%	2,167,172	$12,721,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	1,078,158	$6,328,000	—	31 Mar 2021	13F
NOMURA HOLDINGS INC	13F	Company	0.21%	918,767	$5,401,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.18%	750,385	$4,405,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.16%	705,137	$4,140,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.14%	596,231	$3,499,000	—	31 Mar 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.11%	474,592	$2,786,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.11%	470,338	$2,761,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.11%	462,296	$2,713,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.1%	446,027	$2,618,000	—	31 Mar 2021	13F
Boothe Investment Group, Inc.	13F	Company	0.1%	435,939	$2,559,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	423,226	$2,485,000	—	31 Mar 2021	13F
Eversept Partners, LP	13F	Company	0.1%	410,593	$2,410,181	—	31 Mar 2021	13F
AXA S.A.	13F	Company	0.09%	402,300	$2,362,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.09%	393,886	$2,312,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.07%	312,479	$1,834,000	—	31 Mar 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.06%	242,187	$1,421,000	—	31 Mar 2021	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.06%	239,187	$1,404,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.05%	201,416	$1,182,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	183,687	$1,078,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	183,086	$1,075,000	—	31 Mar 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.04%	181,862	$1,067,000	—	31 Mar 2021	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.04%	179,800	$1,055,000	—	31 Mar 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.04%	171,873	$1,009,000	—	31 Mar 2021	13F
WINTON GROUP Ltd	13F	Company	0.04%	163,669	$961,000	—	31 Mar 2021	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.04%	150,363	$883,000	—	31 Mar 2021	13F
NISA INVESTMENT ADVISORS, LLC	13F	Company	0.03%	140,000	$822,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	132,492	$778,000	—	31 Mar 2021	13F
STRS OHIO	13F	Company	0.03%	118,800	$697,000	—	31 Mar 2021	13F
Campbell & CO Investment Adviser LLC	13F	Company	0.02%	103,100	$605,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.02%	102,931	$604,000	—	31 Mar 2021	13F
NATIXIS ADVISORS, LLC	13F	Company	0.02%	94,859	$556,000	—	31 Mar 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.02%	92,701	$544,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	87,998	$517,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	0.02%	87,497	$514,000	—	31 Mar 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.02%	85,615	$503,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	84,600	$497,000	—	31 Mar 2021	13F
Vontobel Holding Ltd.	13F	Company	0.02%	80,000	$470,000	—	31 Mar 2021	13F
STIFEL FINANCIAL CORP	13F	Company	0.02%	77,918	$457,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	75,010	$440,000	—	31 Mar 2021	13F
SALEM INVESTMENT COUNSELORS INC	13F	Company	0.02%	73,000	$429,000	—	31 Mar 2021	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.02%	66,299	$389,000	—	31 Mar 2021	13F

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) as of Q2 2021

As of 30 Jun 2021, LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) was held by 105 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 117,708,489 shares. The largest 10 holders included Artal Group S.A., BVF INC/IL, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., NEA Management Company, LLC, PINNACLE ASSOCIATES LTD, JPMORGAN CHASE & CO, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 105 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

103

Q2 2021 holders

105

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.